Intra-Cellular Therapies Total Current Assets 2013-2024 | ITCI
- Intra-Cellular Therapies total current assets for 2023 were $0.668B, a 9.51% decline from 2022.
- Intra-Cellular Therapies total current assets for 2022 were $0.738B, a 57.93% increase from 2021.
- Intra-Cellular Therapies total current assets for 2021 were $0.467B, a 32.37% decline from 2020.